Recording TB treatment results

Clinical description

It is vital, for assessing programme performance, that accurate recording of treatment outcome results is entered in the TB registers and treatment cards for ALL patients. Treatment cards for patients who have completed treatment, died or defaulted must be collected from health centres. These treatment cards must be kept safely and in chronological order in the TB office.

At the end of treatment, results of chemotherapy should be recorded as per treatment outcomes.

Table 7.1-8: Management of New TB treatment interrupters Duration of Recommended Results, if any Recommended intervention interruption Action Interrupted 1) Trace the patient No lab • Continue treatment and add the missed treatment for investigation doses at the end of the treatment phase 2) Establish the less than 1 required cause for treatment • If the interruption occurred during the month interruption intensive phase, the duration of this phase must be extended by the number of 3) Address the missed days.

problem or concerns/ counsel • If the interruption occurred during the patient continuation phase, the duration of this phase must be extended by the number of missed days Interrupts 1) Address causes for Xpert MTB Continue treatment and add the missed doses treatment for interruption with the positive and at the end of the treatment phase 1-2 months patient rifampicin sensitive 2) Collect sputum for Xpert MTB • Stop treatment rapid DST, preferably positive and Xpert MTB/Rif • Register patient as “RR-TB” rifampicin resistant (with • Refer to the MDR-TB treatment initiating 3) Continue same repeat test) site for further management treatment from Xpert detects no • Continue same regimen where it stopped, and MTB / Xpert not wait for DST results • Arrange sputum sample referral for DST done /Xpert not for any further action available • Decide on next action based on DST result Interrupted 1) Address causes for Xpert positive • Stop treatment treatment for interruption with and rifampicin

• Register patient as “RR-TB”

two months or patient resistant (repeat more (lost to test) • Refer to MDR-TB treatment initiating site for 2) Collect sputum for follow-up) further management rapid DST, preferably Xpert” National Tuberculosis Control Programme 59